First American Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.05M | Sell |
11,348
-5,663
| -33% | -$2.52M | 0.4% | 78 |
|
|
2025
Q1 | $8.25M | Buy |
17,011
+514
| +3% | +$249K | 0.76% | 40 |
|
|
2024
Q4 | $6.64M | Sell |
16,497
-20
| -0.1% | -$8.05K | 0.66% | 52 |
|
|
2024
Q3 | $7.68M | Sell |
16,517
-2,275
| -12% | -$1.06M | 0.76% | 45 |
|
|
2024
Q2 | $8.81M | Buy |
18,792
+971
| +5% | +$455K | 0.88% | 38 |
|
|
2024
Q1 | $7.45M | Buy |
17,821
+521
| +3% | +$218K | 0.78% | 42 |
|
|
2023
Q4 | $7.04M | Sell |
17,300
-5,689
| -25% | -$2.31M | 0.87% | 43 |
|
|
2023
Q3 | $7.99M | Sell |
22,989
-529
| -2% | -$184K | 1.13% | 31 |
|
|
2023
Q2 | $8.28M | Buy |
23,518
+805
| +4% | +$283K | 1.14% | 26 |
|
|
2023
Q1 | $7.16M | Buy |
22,713
+1,022
| +5% | +$322K | 1.06% | 34 |
|
|
2022
Q4 | $6.26M | Buy |
21,691
+860
| +4% | +$248K | 0.97% | 40 |
|
|
2022
Q3 | $6.03M | Buy |
20,831
+858
| +4% | +$248K | 1.01% | 36 |
|
|
2022
Q2 | $5.63M | Buy |
+19,973
| New | +$5.63M | 0.89% | 46 |
|